| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A diagnostic strategy for Parkinsonian syndromes using quantitative indices of DAT SPECT and MIBG scintigraphy: an investigation using the classification and regression tree analysis
|
Iwabuchi, Yu
|
|
|
48 |
6 |
p. 1833-1841
|
artikel
|
| 2 |
Advanced analytics and artificial intelligence in gastrointestinal cancer: a systematic review of radiomics predicting response to treatment
|
Wesdorp, Nina J.
|
|
|
48 |
6 |
p. 1785-1794
|
artikel
|
| 3 |
Biodistribution, pharmacokinetics, dosimetry of [68Ga]Ga-DOTA.SA.FAPi, and the head-to-head comparison with [18F]F-FDG PET/CT in patients with various cancers
|
Ballal, Sanjana
|
|
|
48 |
6 |
p. 1915-1931
|
artikel
|
| 4 |
Cardiac transthyretin amyloidosis 99mTc-DPD SPECT correlates with strain echocardiography and biomarkers
|
Löfbacka, Viktor
|
|
|
48 |
6 |
p. 1822-1832
|
artikel
|
| 5 |
Clinical perspectives for the use of total body PET/CT
|
Abgral, Ronan
|
|
|
48 |
6 |
p. 1712-1718
|
artikel
|
| 6 |
[11C]MODAG-001—towards a PET tracer targeting α-synuclein aggregates
|
Kuebler, Laura
|
|
|
48 |
6 |
p. 1759-1772
|
artikel
|
| 7 |
Comparison of MRI, [18F]FDG PET/CT, and 99mTc-UBI 29-41 scintigraphy for postoperative spondylodiscitis—a prospective multicenter study
|
Paez, Diana
|
|
|
48 |
6 |
p. 1864-1875
|
artikel
|
| 8 |
Correction to: [18F]FDG -PET/CT uptake reveals a single metastasis inside vertebral hemangioma, catch me if you scan
|
Cohen, Yogev
|
|
|
48 |
6 |
p. 2066
|
artikel
|
| 9 |
Correction to: 68Ga-FAPI outperforms 18F-FDG PET/CT in identifying solitary fibrous tumor
|
Wang, Rongxi
|
|
|
48 |
6 |
p. 2064-2065
|
artikel
|
| 10 |
Diagnostic value of [18F]FDG-PET/CT in polymyalgia rheumatica: a systematic review and meta-analysis
|
van der Geest, K. S. M.
|
|
|
48 |
6 |
p. 1876-1889
|
artikel
|
| 11 |
[18F]DCFPyL PET/CT in detection and localization of recurrent prostate cancer following prostatectomy including low PSA < 0.5 ng/mL
|
Perry, Elisa
|
|
|
48 |
6 |
p. 2038-2046
|
artikel
|
| 12 |
FDG PET/CT parameters and correlations with tumor-absorbed doses in a phase 1 trial of 177Lu-lilotomab satetraxetan for treatment of relapsed non-Hodgkin lymphoma
|
Løndalen, Ayca
|
|
|
48 |
6 |
p. 1902-1914
|
artikel
|
| 13 |
18F-FDG PET/CT and MRI findings of Shulman syndrome also known as eosinophilic fasciitis
|
Barlet, Juliette
|
|
|
48 |
6 |
p. 2049-2050
|
artikel
|
| 14 |
[18F]FDG -PET/CT uptake reveals a single metastasis inside vertebral hemangioma - Catch me if you scan
|
Cohen, Yogev
|
|
|
48 |
6 |
p. 2062-2063
|
artikel
|
| 15 |
[18F]-JK-PSMA-7 and [18F]-FDG tumour PET uptake in treated xenograft human prostate cancer model in mice
|
Van Simaeys, Gaetan
|
|
|
48 |
6 |
p. 1773-1784
|
artikel
|
| 16 |
18F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary results
|
Mittlmeier, L. M.
|
|
|
48 |
6 |
p. 2031-2037
|
artikel
|
| 17 |
68Ga-FAPI outperforms 18F-FDG PET/CT in identifying solitary fibrous tumor
|
Wang, Rongxi
|
|
|
48 |
6 |
p. 2055-2056
|
artikel
|
| 18 |
[68Ga]Ga-DOTA-FAPI-04 PET/CT imaging of benign pulmonary solitary fibrous tumour
|
Liu, Huipan
|
|
|
48 |
6 |
p. 2053-2054
|
artikel
|
| 19 |
[68Ga]Ga-FAPI and [18F]FDG PET/CT images in a patient with juvenile polymyositis
|
Zheng, Jieling
|
|
|
48 |
6 |
p. 2051-2052
|
artikel
|
| 20 |
Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [18F]FDG PET-CT and relevance to study interpretation
|
Cohen, Dan
|
|
|
48 |
6 |
p. 1854-1863
|
artikel
|
| 21 |
Improved amyloid burden quantification with nonspecific estimates using deep learning
|
Liu, Haohui
|
|
|
48 |
6 |
p. 1842-1853
|
artikel
|
| 22 |
Interim [18F]FDG PET/CT can predict response to anti-PD-1 treatment in metastatic melanoma
|
Sachpekidis, Christos
|
|
|
48 |
6 |
p. 1932-1943
|
artikel
|
| 23 |
Medical imaging in times of pandemic: focus on the cornerstones of successful imaging
|
Delgado Bolton, Roberto C.
|
|
|
48 |
6 |
p. 1724-1725
|
artikel
|
| 24 |
NEMA NU2-2012 performance measurements of the United Imaging uPMR790: an integrated PET/MR system
|
Chen, Shuguang
|
|
|
48 |
6 |
p. 1726-1735
|
artikel
|
| 25 |
Optimal method for metabolic tumour volume assessment of cervical cancers with inter-observer agreement on [18F]-fluoro-deoxy-glucose positron emission tomography with computed tomography
|
Arshad, Mubarik A.
|
|
|
48 |
6 |
p. 2009-2023
|
artikel
|
| 26 |
PET/MRI assessment of lung nodules in primary abdominal malignancies: sensitivity and outcome analysis
|
Biondetti, Pierpaolo
|
|
|
48 |
6 |
p. 1976-1986
|
artikel
|
| 27 |
Physiological FAP-activation in a postpartum woman observed in oncological FAPI-PET/CT
|
Dendl, Katharina
|
|
|
48 |
6 |
p. 2059-2061
|
artikel
|
| 28 |
Predicting tumor response and outcome of second-look surgery with 18F-FDG PET/CT: insights from the GINECO CHIVA phase II trial of neoadjuvant chemotherapy plus nintedanib in stage IIIc-IV FIGO ovarian cancer
|
Aide, Nicolas
|
|
|
48 |
6 |
p. 1998-2008
|
artikel
|
| 29 |
Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy
|
Michalski, Kerstin
|
|
|
48 |
6 |
p. 2024-2030
|
artikel
|
| 30 |
Prognostic value of SPECT myocardial perfusion entropy in high-risk type 2 diabetic patients
|
Djaileb, Loïc
|
|
|
48 |
6 |
p. 1813-1821
|
artikel
|
| 31 |
PSMA-PET: is the time to say goodbye to metabolic radiopharmaceuticals in prostate cancer?
|
Evangelista, Laura
|
|
|
48 |
6 |
p. 1709-1711
|
artikel
|
| 32 |
Quantification of perivascular inflammation does not provide incremental prognostic value over myocardial perfusion imaging and calcium scoring
|
Bengs, Susan
|
|
|
48 |
6 |
p. 1806-1812
|
artikel
|
| 33 |
Reply to: Quantification of perivascular inflammation does not provide incremental prognostic value over myocardial perfusion imaging and calcium scoring
|
Antonopoulos, Alexios S.
|
|
|
48 |
6 |
p. 1707-1708
|
artikel
|
| 34 |
Role of [68Ga]Ga-DOTA-FAPI-04 PET/CT in the evaluation of peritoneal carcinomatosis and comparison with [18F]-FDG PET/CT
|
Zhao, Liang
|
|
|
48 |
6 |
p. 1944-1955
|
artikel
|
| 35 |
SARS-CoV-2-related thyroid disorders: a synopsis for nuclear medicine thyroidologists
|
Giovanella, Luca
|
|
|
48 |
6 |
p. 1719-1723
|
artikel
|
| 36 |
Sequential implementation of DSC-MR perfusion and dynamic [18F]FET PET allows efficient differentiation of glioma progression from treatment-related changes
|
Steidl, Eike
|
|
|
48 |
6 |
p. 1956-1965
|
artikel
|
| 37 |
Structural and metabolic brain abnormalities in COVID-19 patients with sudden loss of smell
|
Niesen, Maxime
|
|
|
48 |
6 |
p. 1890-1901
|
artikel
|
| 38 |
Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [68Ga]Ga-PSMA-11 PET/MRI
|
Papp, L.
|
|
|
48 |
6 |
p. 1795-1805
|
artikel
|
| 39 |
Systematic imaging in medicine: a comprehensive review
|
Zhang, Kai
|
|
|
48 |
6 |
p. 1736-1758
|
artikel
|
| 40 |
The PSMA-11-derived hybrid molecule PSMA-914 specifically identifies prostate cancer by preoperative PET/CT and intraoperative fluorescence imaging
|
Eder, Ann-Christin
|
|
|
48 |
6 |
p. 2057-2058
|
artikel
|
| 41 |
Total-body PET/CT using half-dose FDG and compared with conventional PET/CT using full-dose FDG in lung cancer
|
Tan, Hui
|
|
|
48 |
6 |
p. 1966-1975
|
artikel
|
| 42 |
Uncovering the invisible—prevalence, characteristics, and radiomics feature–based detection of visually undetectable intraprostatic tumor lesions in 68GaPSMA-11 PET images of patients with primary prostate cancer
|
Zamboglou, Constantinos
|
|
|
48 |
6 |
p. 1987-1997
|
artikel
|
| 43 |
Whole-body parametric [18F]-FDG PET/CT improves interpretation of a distant lesion as venous embolus in a lung cancer patient
|
Messerli, Michael
|
|
|
48 |
6 |
p. 2047-2048
|
artikel
|
Tijdschrift beschrijving